RET and adrenal gland pheochromocytoma: Also, PCC is rarely the first clinical manifestation of MEN2 and, when this occurs, is most frequently associated with RET mutations in the codon 634, whose patients invariably have medullary thyroid carcinoma at the ages at which they were diagnosed with PCC.